All together, we observed a clear trend toward greater protection with higher systemic TDF doses and higher TFV plasma concentrations.
← all excerpts
Predicting HIV Pre-exposure Prophylaxis Efficacy for Women using a Preclinical Pharmacokinetic-Pharmacodynamic In Vivo Model.
1
—
—